Predictors of Internal Mammary Artery Graft Failure

The Internal Mammary Artery (IMA) is the preferred conduit for bypassing the left anterior descending artery (LAD) in patients undergoing coronary artery bypass grafting. There is no systematic evaluation of the frequency and predictors of IMA failure or long-term outcomes.

 

The PREVENT IV included 1539 patients receiving IMA-LAD revascularization with 12 and 18 month follow up. Logistic regression was used to identify characteristics associated with IMA failure (≥75% stenosis) and itsconnectionwith clinical events such as death, myocardial infarction, and repeat revascularization.

 

IMA failure occurred in 132 patients (8.6%). Predictors of IMA graft failure were LAD stenosis <75% (OR 1.76; CI 95% 1.19-2.59), additional bypass graft to diagonal branch (OR 1.92; CI 95% 1.33-2.76), and not having diabetes (OR 1.82; CI 95% 1.20-2.78).

 

IMA failure was associated with a higher incidence of AMI mostly due to a higher rate of repeat revascularization.

 

Conclusion
IMA failure is associated to clinical events and is observed mainly in patients with a prior intermediate LAD stenosis or with an additional bypass graft to a diagonal branch. This finding should be taken into account when indication surgery for patients with no functional evidence of ischemia in LAD territory.

 

Original Title: Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the PREVENT IV Trial. Reference: Ralf E. Harskamp et al. Circulation. 2015 Dec 8.Epub ahead of print.


Suscríbase a nuestro newsletter semanal

Reciba resúmenes con los últimos artículos científicos

Su opinión nos interesa. Puede dejar su comentario, reflexión, pregunta o lo que desee aquí abajo. Será más que bienvenido.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....